Molecular laboratories are facing a significant increase in testing for respiratory pathogens due to the COVID-19 global health crisis. Increased testing demands require flexible and automated platforms to enable laboratories to meet respiratory testing needs during the pandemic as well as for routine testing and testing during the flu season.
The VERSANT® kPCR Molecular System1 for PCR testing provides true molecular testing versatility. The VERSANT kPCR Molecular System, delivering accurate and reliable results with maximum productivity and flexibility, enables molecular laboratories to meet emerging challenges as well as routine needs in molecular diagnostic testing.
The VERSANT kPCR Molecular System, along with the VERSANT Sample Preparation 1.0 Reagents Kit, has been validated for use with the FTD SARS-CoV-2 Assay2 and the FTD SARS-CoV-2/FluA/FluB/HRSV Assay†. This total solution has been demonstrated to have one of the lowest limits of detection (LoD; sensitivity) when compared to other COVID-19 PCR tests.3
CE-marked for in vitro diagnostic use in the EU.